What is in action?

Publicado em 23/06/2025 23:05

Anvisa has ordered the recall and suspension of batch 2408J5 of PROTEIN SUPPLEMENT FOR ATHLETES - 100% FULL WHEY, BRAND FULLIFE NUTRITION, from the company SFS ALIMENTOS LTDA.

The measure was adopted after a laboratory analysis identified the presence of gluten, with the detection of wheat, rye and barley in the product, which differed from what was stated on the label. The assessment also identified claims that were not allowed on the label, leading to misleading information for consumers.

The analysis of the 100% Full Whey Supplement was carried out by the Ezequiel Dias Foundation (Funed/Lacen-MG).

Cinnamon

The Agency also ordered the recall and suspension of batch 371LAG2419 of CANELA-DA-CHINA EM PÓ, MARCA KININO, from the company H.L. DO BRASIL INDÚSTRIA E COM. DE PRODUTOS ALIMENTÍCIOS LTDA.

The determination is the result of an analysis verifying the presence of starch, which is not a characteristic component of cinnamon. The product also had unsatisfactory results in the evaluation of histological elements and in the search for macroscopic and microscopic foreign matter. The parameters identified were not in accordance with health legislation.

The evaluation of the Kinino cinnamon batch was also carried out by Funed.

Source:  https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2025/anvisa-suspende-suplemento-e-canela-em-po-por-resultados-insatisfatorios

Publicado em 23/06/2025 23:05

Pharmacies and drugstores throughout Brazil must now retain prescriptions for GLP-1 agonist drugs, such as Ozempic and Mounjaro, as of Monday, June 23. Anvisa implemented this measure (IN 360/2025) to increase control over the use of these "slimming pens" - widely used in the treatment of type 2 diabetes and obesity - due to the high number of adverse events from improper use. Medical prescriptions now require two copies, and the validity of the prescription is 90 days, working in a similar way to the sale of antibiotics.

Source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2025/entra-em-vigor-norma-que-preve-retencao-de-receita-para-medicamentos-agonistas-glp-1